HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jagadeesh S Rao Selected Research

Arachidonic Acid (Vitamin F)

8/2012Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.
8/2012Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.
10/2011Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.
1/2011Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex.
3/2010Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients.
2/2010Brain lipid concentrations in bipolar disorder.
5/2008Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex.
1/2008Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat.
11/2007Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism.
9/2007Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Jagadeesh S Rao Research Topics

Disease

18Bipolar Disorder (Mania)
08/2012 - 10/2005
3Alzheimer Disease (Alzheimer's Disease)
01/2014 - 01/2011
2Schizophrenia (Dementia Praecox)
05/2013 - 08/2012
1Infection
05/2012
1Amyloid Plaque
01/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2011
1Atrophy
03/2010
1Brain Diseases (Brain Disorder)
11/2008
1Body Weight (Weight, Body)
08/2007
1Mood Disorders (Mood Disorder)
01/2007
1Depressive Disorder (Melancholia)
01/2007

Drug/Important Bio-Agent (IBA)

13Arachidonic Acid (Vitamin F)IBA
08/2012 - 10/2005
7Carbamazepine (Tegretol)FDA LinkGeneric
06/2009 - 10/2005
5N-Methylaspartate (NMDA)IBA
08/2012 - 09/2007
5lamotrigine (Lamictal)FDA LinkGeneric
08/2012 - 09/2007
5PhospholipidsIBA
10/2011 - 10/2005
5LithiumIBA
06/2009 - 10/2005
5Valproic Acid (Valproate, Semisodium)FDA LinkGeneric
06/2009 - 10/2005
3Transcription Factors (Transcription Factor)IBA
06/2009 - 08/2007
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2014 - 06/2009
2EnzymesIBA
01/2011 - 06/2009
2GTP-Binding Proteins (G-Protein)IBA
07/2009 - 01/2007
2Phospholipases (Phospholipase)IBA
06/2009 - 09/2007
2NF-kappa B (NF-kB)IBA
06/2009 - 08/2007
1Cholesterol Esters (Cholesteryl Esters)IBA
05/2013
1Clozapine (Clozaril)FDA LinkGeneric
08/2012
1gabapentin (Neurontin)FDA LinkGeneric
08/2012
1Proteins (Proteins, Gene)IBA
05/2012
1olanzapine (Zyprexa)FDA Link
10/2011
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2011
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2011
1choline plasmalogensIBA
01/2011
1Amyloid (Amyloid Fibrils)IBA
01/2011
1Antidepressive Agents (Antidepressants)IBA
10/2009
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2009
1Messenger RNA (mRNA)IBA
03/2009
1Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2009
1Antimanic AgentsIBA
11/2007
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2007
1CalciumIBA
09/2007
1Fluoxetine (Prozac)FDA LinkGeneric
01/2007
1Serotonin (5 Hydroxytryptamine)IBA
01/2007
112- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA
03/2006